SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is experiencing significant volatility and community debate after pulling its compounded GLP-1 drug amid a patent infringement lawsuit from Novo Nordisk and increased regulatory scrutiny. Investors are sharply divided between calls for a short squeeze and a rebound from oversold levels, and predictions of further downside due to ongoing legal and business model challenges.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies ($PGY) is trending due to a significant market sell-off following its Q4 earnings, where conservative guidance for the coming year overshadowed stronger-than-expected profitability. The community is debating whether this reflects an extreme overreaction to management's focus on prudent risk management or a deeper concern within the AI-powered fintech sector.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean (RIG) is trending due to its all-stock acquisition of Valaris (VAL), a strategic consolidation that the community largely views as enhancing its market leadership and pricing power in an anticipated offshore drilling upcycle, though some express concerns over share dilution.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl Holdings is currently trending after its stock dramatically dropped following news of an SEC review into its accounting practices, reduced guidance, and the departure of its CFO and General Counsel. The community is sharply divided, with some calling it an extreme "overreaction" and a unique "buy-the-dip" opportunity, while others express severe concerns about potential financial improprieties, urging investors to "stay away" until more clarity emerges.

e.l.f. Beauty, Inc. is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, naturium, well people, and keys soulcare. The company was founded in 2004 and is headquartered in Oakland, CA.

e.l.f. Beauty Inc

ELF Beauty is trending amidst a surprising stock drop following strong earnings and raised guidance, prompting community debate on whether a recent advertisement or market overreaction is to blame for the 'senseless dip' that many investors are seizing as a buying opportunity.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is experiencing a sharp sell-off after issuing a weaker-than-expected revenue outlook and withdrawing its long-term targets, intensifying broader market fears about AI disruption to the traditional software sector. Despite beating Q4 earnings, the community is divided between those viewing the steep decline as an overreaction and a buying opportunity, and others who believe AI poses a fundamental threat to the SaaS business model.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is trending as the community discusses its strategic acquisition of StereoLabs, which creates a unified lidar and camera platform for Physical AI applications. This move is largely seen as strengthening Ouster's market leadership and accelerating its path to profitability through StereoLabs' EBITDA-positive business.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as the community eagerly discusses the recently inaugurated Eagle Line pilot production facility, seen as a pivotal move towards scalable solid-state battery manufacturing and potential new OEM partnerships. Many anticipate its upcoming earnings report will provide crucial commercialization details, potentially fueling a significant market re-rate from current levels.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

REGENXBIO is trending due to intense community speculation surrounding an imminent FDA decision on its RGX-121 gene therapy for Hunter Syndrome, as a recent clinical hold on the program and a related therapy, stemming from a serious adverse event, has many anticipating a Complete Response Letter or a regulatory delay.

Valaris Ltd. engages in the provision of offshore contract drilling services to the international oil and gas industry. It operates through the following segments: Floaters, Jackups, ARO, and Other. The Floaters segment includes drillships and semisubmersible rigs. The Other segment is involved in management services on rigs owned by third-parties and the activities associated with arrangements with ARO under the bareboat charter arrangements. The company was founded in 1975 and is headquartered in Hamilton, Bermuda.

Valaris Ltd

Valaris is trending following its all-stock acquisition by Transocean, a deal prompting active community discussions about the future of offshore drilling and the treatment of Valaris's warrants, alongside strong recent contract awards that bolster its long-term backlog.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why INVO Fertility (IVF) Stock Is Trending Overnight

INVO Fertility shares fell in after-hours trading despite strong gains during the regular session.read more...

Promising Small Cap Stocks To Watch Today - January 20th

Rapt Therapeutics, Corvus Pharmaceuticals, INVO Fertility, Spring Valley Acquisition, Critical Metals, Inflection Point Acquisition, and Direxion Daily MU Bull 2X Shares are the seven Small Cap...

Healthcare Stocks To Follow Now - January 20th

Johnson & Johnson, UnitedHealth Group, and INVO Fertility are the three Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of publicly...

<ul class="summary-bullets"><li>Last month, INVO Fertility signed a definitive agreement to acquire Family Beginnings, a fertility clinic.</li><li>INVO Fertility also announced a private placement worth $4 million last month.</li><li>Terah Krigsvold recently took over as IVF’s chief financial officer, replacing Andrea Goren.</li></ul>INVO Fertility, Inc. (IVF) shares drew significant retail interest on Tuesday, with the stock soaring 350% in premarket trading.Retail watchers for <a href="https://stocktwits.com/symbol/INVO">IVF stock</a> increased a whopping 726% over the last 24 hours and 3,700% over seven days, according to Stocktwits data. Retail sentiment on Stocktwits was ‘extremely bullish’ over the past 24 hours, accompanied by ‘extremely high’ message volumes.<img src="https://news.stocktwits-cdn.com/INVO_jpg_f619340f95.webp" alt="INVO.jpg">A few users speculated on U.S. President Donald Trump cutting costs for fertility treatments.<stembedurl>https://stocktwits.com/DekmarTrades/message/642263565</stembedurl>While others saw a classic pump-and-dump scheme.<stembedurl>https://stocktwits.com/Bonanza2252003/message/642265944</stembedurl>The speculation stems from an October 2025 report on Trump and Merck’s agreeing to reduce the cost of drugs used in in vitro fertilization. Merck’s U.S. unit, EMD Serono, will sell key fertility treatments directly to patients, offering up to an 84% discount when the drugs are used together.<h2 class="st-heading-2">Why Has Retail Been Tracking IVF?</h2>Last month, INVO Fertility signed a definitive agreement to acquire Family Beginnings, P.C., a fertility clinic serving Indiana and the broader Midwest. The deal allows INVO to strategize to expand its network of fertility care centers across the United States.INVO will acquire the non-clinical assets for $750,000, consisting of $350,000 in cash at closing, net of a $150,000 holdback, and $400,000 in Series D non-voting convertible preferred stock. Family Beginnings generated approximately $1.2 million in revenue and $0.2 million in net income over the past year.Prior to that, INVO Fertility announced a private placement with a single institutional investor to sell 2.37 million shares, or pre-funded warrants, along with warrants for up to 4.73 million additional shares, at an effective price of $1.69 per share. The offering generated around $4 million in gross proceeds.Recently, Terah Krigsvold, who has served as INVO’s controller since December 2020, was appointed the Company’s CFO, replacing Andrea Goren. INVO Fertility also implemented a one-for-eight reverse stock split on Nov. 28, 2025.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-ibrx-stock-surging-premarket-fda-anktiva-resubmission/cmUujB3R4aL">IBRX Stock Extends Rally On FDA Feedback For ANKTIVA Bladder Cancer Filing</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

INVO Fertility’s 350% Spike Puts Microcap IVF Stocks Back On Retail Radar

Retail watchers for IVF stock increased a whopping 726% over the last 24 hours and 3,700% over seven days, according to Stocktwits data.

A Little-Known Fertility Stock Soared 350% — Here’s What Traders Are Watching

Equity

INVO Fertility, Inc. operates as a revenue-generating fertility business. It also focuses on the development of class clinical-stage assets in oncology and autoimmune diseases. The company was founded on January 5, 2007 and is headquartered in Sarasota, FL.

INVO Fertility Inc.

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

IVF
INVO Fertility, Inc. Common Stock

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest IVF News

IVFINVO Fertility, Inc. Common Stock